CTKB (Cytek Biosciences) Float Percentage Of Total Shares Outstanding: 78.91% (As of Jun. 27, 2026)


CTKB Cytek Biosciences Inc CTKB
71 GF Score
Price $4.46
GF Value $5.82
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cytek Biosciences Float Percentage Of Total Shares Outstanding?

Cytek Biosciences CTKB +0.11% 71 Float Percentage Of Total Shares Outstanding is 78.91% as of Jun. 27, 2026. GuruFocus rates CTKB with a GF Score™ of 71/100 and a GF Value™ of $5.82 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cytek Biosciences's float shares is 101.90 Mil. Cytek Biosciences's total shares outstanding is 129.14 Mil. Cytek Biosciences's float percentage of total shares outstanding is 78.91%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cytek Biosciences's Insider Ownership is 8.54%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cytek Biosciences's Institutional Ownership is 71.68%.

CTKB
71GF Score
Cytek Biosciences Inc CTKB
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cytek Biosciences Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Cytek Biosciences's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=101.90/129.14
=78.91%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 78.91% mean?
Cytek Biosciences (CTKB) has a Float Percentage Of Total Shares Outstanding of 78.91% as of Jun. 27, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Cytek Biosciences and its competitors.
Is Cytek Biosciences' Float Percentage Of Total Shares Outstanding too high?
Cytek Biosciences' current Float Percentage Of Total Shares Outstanding is 78.91%. Overall, Cytek Biosciences has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cytek Biosciences' Float Percentage Of Total Shares Outstanding compare to BBNX and TCMD?
Cytek Biosciences' Float Percentage Of Total Shares Outstanding of 78.91% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Medical Devices & Instruments company?
A good Float Percentage Of Total Shares Outstanding depends on the Medical Devices & Instruments industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Cytek Biosciences and its competitors. Cytek Biosciences's current Float Percentage Of Total Shares Outstanding is 78.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cytek Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Cytek Biosciences (CTKB) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.82, compared to a current price of $4.46 — trading 23.4% below its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 78.91%. Cytek Biosciences' overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Cytek Biosciences (CTKB), the current Float Percentage Of Total Shares Outstanding is 78.91% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cytek Biosciences (CTKB) Overvalued in 2026?

Based on GuruFocus' analysis, Cytek Biosciences stock appears to be undervalued. The current stock price of $4.46 is trading 23.4% below its estimated GF Value™ of $5.82. GuruFocus considers Cytek Biosciences to be Modestly Undervalued.

Key valuation signals for CTKB:

  • Float Percentage Of Total Shares Outstanding: 78.91%
  • GF Value™: $5.82 vs. price of $4.46 (23.4% below fair value)
  • GF Score™: 71/100 with 5 warning signs

No single metric tells the full story. See the CTKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cytek Biosciences Business Description

Other Exchanges 8EQ:Germany
Address 47215 Lakeview Boulevard, Fremont, CA, USA, 94538
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
71GF Score

Get the complete analysis for CTKB

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.46
Price
$5.82
GF Value